Wei Wei Chen - 06 Apr 2022 Form 4 Insider Report for LianBio (LIANY)

Role
Director
Signature
By: /s/ Angela Chen, Attorney-in-Fact
Issuer symbol
LIANY
Transactions as of
06 Apr 2022
Net transactions value
$0
Form type
4
Filing time
08 Apr 2022, 16:27:49 UTC
Next filing
23 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIAN Stock Option (Right to Buy) Award $0 +72,600 $0.000000 72,600 06 Apr 2022 Ordinary Shares 72,600 $4.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36 of the shares underlying the option will become exercisable on 05/06/2022; the remainder shall vest and become exercisable in 35 equal monthly installments such that the option shall be fully vested on 04/06/2025, subject to the Reporting Person providing continuous service to the Issuer on each such date.